- CA$3.31bn
- CA$7.74bn
- CA$853.00m
- 57
- 34
- 63
- 50
Annual income statement for Boralex, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 633 | 691 | 836 | 1,022 | 853 |
Cost of Revenue | |||||
Gross Profit | 482 | 538 | 578 | 642 | 655 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 472 | 513 | 728 | 799 | 663 |
Operating Profit | 161 | 178 | 108 | 223 | 190 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 66 | 44 | 18 | 154 | 110 |
Provision for Income Taxes | |||||
Net Income After Taxes | 61 | 26 | 8 | 115 | 74 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 55 | 17 | 30 | 78 | 36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 55 | 17 | 30 | 78 | 36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.727 | 0.211 | 0.677 | 0.926 | 0.618 |
Dividends per Share |